Notably, anti‐PD‐1 therapy diminished the difference in tumor growth between WT and CBX4 KO mice (Fig. 1I,J), suggesting that the accelerated tumor development due to Cbx4 deficiency is mainly determined by their enhanced PD‐1 expression. This evidence concerns the gene PDCD1 and neoplasm.